127.15
Schlusskurs vom Vortag:
$121.40
Offen:
$122.29
24-Stunden-Volumen:
881.65K
Relative Volume:
1.09
Marktkapitalisierung:
$7.15B
Einnahmen:
$633.51M
Nettoeinkommen (Verlust:
$-8.10M
KGV:
-410.16
EPS:
-0.31
Netto-Cashflow:
$131.26M
1W Leistung:
+13.43%
1M Leistung:
-2.34%
6M Leistung:
-13.01%
1J Leistung:
-22.72%
Repligen Corp Stock (RGEN) Company Profile
Firmenname
Repligen Corp
Sektor
Telefon
(781) 449-9560
Adresse
41 SEYON STREET, WALTHAM, MA
Vergleichen Sie RGEN mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
RGEN
Repligen Corp
|
127.15 | 6.83B | 633.51M | -8.10M | 131.26M | -0.31 |
![]()
ISRG
Intuitive Surgical Inc
|
482.35 | 171.42B | 9.15B | 2.61B | 1.99B | 7.17 |
![]()
BDX
Becton Dickinson Co
|
195.96 | 55.88B | 21.39B | 1.59B | 2.55B | 5.56 |
![]()
ALC
Alcon Inc
|
86.48 | 42.55B | 9.93B | 1.12B | 1.58B | 2.25 |
![]()
RMD
Resmed Inc
|
288.28 | 41.48B | 5.15B | 1.40B | 1.65B | 9.51 |
![]()
WST
West Pharmaceutical Services Inc
|
246.22 | 17.25B | 2.90B | 467.20M | 306.90M | 6.37 |
Repligen Corp Stock (RGEN) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-07-22 | Fortgesetzt | Stephens | Overweight |
2025-06-24 | Eingeleitet | Barclays | Overweight |
2025-04-29 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
2025-03-18 | Eingeleitet | Evercore ISI | In-line |
2025-02-10 | Eingeleitet | TD Cowen | Buy |
2024-12-17 | Eingeleitet | Canaccord Genuity | Hold |
2024-11-14 | Eingeleitet | Wolfe Research | Peer Perform |
2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
2024-06-26 | Hochstufung | Deutsche Bank | Hold → Buy |
2024-06-18 | Eingeleitet | Guggenheim | Neutral |
2023-12-04 | Herabstufung | The Benchmark Company | Buy → Hold |
2023-07-20 | Eingeleitet | Wells Fargo | Overweight |
2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
2023-03-28 | Eingeleitet | The Benchmark Company | Buy |
2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
2022-12-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
2022-07-20 | Eingeleitet | UBS | Buy |
2021-10-14 | Eingeleitet | Exane BNP Paribas | Outperform |
2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
2020-08-24 | Bestätigt | H.C. Wainwright | Buy |
2020-06-30 | Bestätigt | H.C. Wainwright | Buy |
2020-05-07 | Bestätigt | H.C. Wainwright | Buy |
2020-03-23 | Bestätigt | H.C. Wainwright | Buy |
2019-11-15 | Eingeleitet | Stifel | Buy |
2019-11-01 | Hochstufung | First Analysis Sec | Outperform → Strong Buy |
2019-10-15 | Eingeleitet | SVB Leerink | Outperform |
2019-08-28 | Bestätigt | First Analysis Sec | Outperform |
2019-08-23 | Fortgesetzt | Stephens | Overweight |
2019-07-22 | Hochstufung | H.C. Wainwright | Neutral → Buy |
2018-12-17 | Hochstufung | CL King | Neutral → Buy |
2018-11-12 | Herabstufung | CL King | Buy → Neutral |
2018-09-26 | Eingeleitet | H.C. Wainwright | Neutral |
2017-12-08 | Eingeleitet | Citigroup | Buy |
2017-12-05 | Eingeleitet | JP Morgan | Overweight |
2017-11-13 | Eingeleitet | CL King | Buy |
2017-10-02 | Hochstufung | First Analysis Sec | Equal-Weight → Overweight |
2017-07-21 | Eingeleitet | William Blair | Outperform |
2017-02-13 | Hochstufung | Piper Jaffray | Neutral → Overweight |
Alle ansehen
Repligen Corp Aktie (RGEN) Neueste Nachrichten
Using fundamentals and technicals on Repligen CorporationPortfolio Gains Report & Proven Capital Preservation Methods - Newser
Why Repligen Corporation stock attracts strong analyst attentionWatch List & AI Driven Stock Price Forecasts - Newser
Can machine learning forecast Repligen Corporation recoveryPortfolio Return Summary & Real-Time Buy Signal Notifications - Newser
Will earnings trigger a reversal in Repligen CorporationTrade Signal Summary & Low Risk Entry Point Guides - Newser
Repligen Corporation stock prediction for this weekAsset Growth Pattern and Return Summary - Newser
How to monitor Repligen Corporation with trend dashboardsFree Sector Based Breakout Stock Forecast - Newser
AMN Healthcare Services, NeoGenomics, Acadia Healthcare, BrightSpring Health Services, and Repligen Shares Are Soaring, What You Need To Know - FinancialContent
Repligen director Madaus buys $201k in shares By Investing.com - Investing.com South Africa
Repligen director Madaus buys $201k in shares - Investing.com
RGEN Q2 Deep Dive: Chromatography and Filtration Drive Growth, Guidance Lifted Amid New Modalities Uncertainty - Yahoo Finance
5 Must-Read Analyst Questions From Repligen’s Q2 Earnings Call - Yahoo Finance
Using economic indicators to assess Repligen Corporation potentialSmart Forecast Signals from AI Models - Newser
Will Repligen Corporation benefit from macro trendsFree Portfolio Diversification Stock Ideas - Newser
Can trapped investors hope for a rebound in Repligen CorporationShort Term Opportunity Finder with Tools - Newser
Will Repligen Corporation rebound enough to break evenFree Pattern Breakout Entry Stock Forecast - Newser
Repligen Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Volatility clustering patterns for Repligen CorporationBuy Signal System Based on Price Action - Newser
How Repligen Corporation stock performs during market volatilityAutomated AI Forecast with Trading Alerts - Newser
Exit strategy if you’re trapped in Repligen CorporationSafe Entry Zone Based on Chart Analysis - Newser
Repligen CorporationCommon Stock (Nasdaq:RGEN) Stock Quote - FinancialContent
Sector ETF performance correlation with Repligen CorporationPattern Recognition Tool for ROI Investors - Newser
Decoding Repligen Corp (RGEN): A Strategic SWOT Insight - GuruFocus
Live market analysis of Repligen CorporationDaily Entry Opportunity Forecasting Tool - Newser
REPLIGEN CORP SEC 10-Q Report - TradingView
Pattern recognition hints at Repligen Corporation upsideFree Fast Gaining Stock Screener Report - Newser
Long term hold vs stop loss in Repligen CorporationFree Expert Verified Stock Trade Ideas - Newser
Repligen (NASDAQ:RGEN) Investors Are Sitting on a Loss of 53% If They Invested Three Years Ago - 富途牛牛
Visual analytics tools that track Repligen Corporation performanceInvestment Roadmap for High Potential Stocks - Newser
Fund Update: GENEVA CAPITAL MANAGEMENT LLC added 343,991 shares of REPLIGEN ($RGEN) to their portfolio - Quiver Quantitative
What Fibonacci levels say about Repligen Corporation reboundFree Access to Smart Investment Tips - Newser
Geneva Capital Management LLC Buys 7,958 Shares of Repligen Corporation (NASDAQ:RGEN) - Defense World
Why is Repligen Corporation stock attracting strong analyst attentionUnlock exclusive trading strategies for gains - Jammu Links News
Can Repligen Corporation recover in the next quarterBuy Signal Forecast With Short-Term Data - Newser
William Blair Analysts Raise Earnings Estimates for Repligen - Defense World
Pacer Advisors Inc. Cuts Stake in Repligen Corporation (NASDAQ:RGEN) - Defense World
Repligen Corporation (NASDAQ:RGEN) Shares Acquired by Nicolet Advisory Services LLC - Defense World
Blueshift Asset Management LLC Takes $458,000 Position in Repligen Corporation (NASDAQ:RGEN) - Defense World
TD Asset Management Inc Has $6.51 Million Position in Repligen Corporation (NASDAQ:RGEN) - Defense World
Evaluating Repligen Corporation with trendline analysisWatchlist Generator With Real-Time Entry - Newser
Q3 Earnings Forecast for Repligen Issued By Leerink Partnrs - Defense World
XTX Topco Ltd Buys 3,295 Shares of Repligen Corporation (NASDAQ:RGEN) - Defense World
Wealthquest Corp Takes Position in Repligen Corporation (NASDAQ:RGEN) - Defense World
Royal Bank Of Canada Raises Repligen (NASDAQ:RGEN) Price Target to $204.00 - Defense World
Repligen Stock Outlook: Risk Skewed To The Downside Through 2026 - Benzinga
Repligen (RGEN) Partners with Novasign to Enhance Filtration Systems - GuruFocus
Repligen Corporation (NASDAQ:RGEN) Q2 2025 Earnings Call Transcript - Insider Monkey
Repligen partners with Novasign to enhance bioprocessing systems - Investing.com
Repligen partners with Novasign to enhance bioprocessing systems By Investing.com - Investing.com Canada
Repligen Announces Strategic Partnership with Novasign to Further Advance Bioprocessing Digitalization - Yahoo Finance
Repligen Corporation (NASDAQ:RGEN) Shares Sold by Norden Group LLC - Defense World
Finanzdaten der Repligen Corp-Aktie (RGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Repligen Corp-Aktie (RGEN) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Hunt Anthony | Director |
May 15 '25 |
Sale |
123.71 |
26,447 |
3,271,688 |
109,854 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):